These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16109648)

  • 1. Experimental autoimmune uveitis induced by immunization with retinal pigment epithelium-specific 65-kDa protein peptides.
    Nakamura H; Yamaki K; Kondo I; Sakuragi S
    Curr Eye Res; 2005 Aug; 30(8):673-80. PubMed ID: 16109648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of retinal pigment epithelium in the development of experimental autoimmune uveitis.
    Konda BR; Pararajasegaram G; Wu GS; Stanforth D; Rao NA
    Invest Ophthalmol Vis Sci; 1994 Jan; 35(1):40-7. PubMed ID: 8300362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with recombinant Escherichia coli expressing retinal S-antigen-induced experimental autoimmune uveitis (EAU) in Lewis rats.
    Eto K; Suzuki S; Singh VK; Shinohara T
    Cell Immunol; 1993 Mar; 147(1):203-14. PubMed ID: 8462112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of uveitogenic sites in phosducin molecule.
    Satoh N; Abe T; Nakajima A; Ohkoshi M; Koizumi T; Tamada H; Sakuragi S
    Curr Eye Res; 1998 Jul; 17(7):677-86. PubMed ID: 9678412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligopeptides of three to five residues derived from uveitopathogenic sites of retinal S-antigen induce experimental autoimmune uveitis (EAU) in Lewis rats.
    Sunil S; Eto K; Singh VK; Shinohara T
    Cell Immunol; 1993 Apr; 148(1):198-207. PubMed ID: 8495487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteopontin is proinflammatory in experimental autoimmune uveitis.
    Hikita ST; Vistica BP; Jones HR; Keswani JR; Watson MM; Ericson VR; Ayoub GS; Gery I; Clegg DO
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4435-43. PubMed ID: 17003437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human interstitial retinoid binding protein. A potent uveitopathogenic agent for the induction of experimental autoimmune uveitis.
    Donoso LA; Merryman CF; Sery T; Sanders R; Vrabec T; Fong SL
    J Immunol; 1989 Jul; 143(1):79-83. PubMed ID: 2786534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of a peptide inhibitor of alpha4-integrin inhibits the development of experimental autoimmune uveitis.
    Martín AP; de Moraes LV; Tadokoro CE; Commodaro AG; Urrets-Zavalia E; Rabinovich GA; Urrets-Zavalia J; Rizzo LV; Serra HM
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2056-63. PubMed ID: 15914623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The onset mechanism of experimental autoimmune uveoretinitis induced by interphotoreceptor retinoid-binding protein].
    Usui M
    Nippon Ganka Gakkai Zasshi; 1992 Dec; 96(12):1580-607. PubMed ID: 1283051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tumor necrosis factor alpha therapy suppresses the induction of experimental autoimmune uveoretinitis in mice by inhibiting antigen priming.
    Sartani G; Silver PB; Rizzo LV; Chan CC; Wiggert B; Mastorakos G; Caspi RR
    Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2211-8. PubMed ID: 8843907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RPE65 is highly uveitogenic in rats.
    Ham DI; Gentleman S; Chan CC; McDowell JH; Redmond TM; Gery I
    Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2258-63. PubMed ID: 12091425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a potent uveitopathogenic site derived from rat phosducin.
    Abe T; Satoh N; Nakajima A; Koizumi T; Tamada M; Sakuragi S
    Exp Eye Res; 1997 Nov; 65(5):703-10. PubMed ID: 9367650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adoptive transfer of experimental autoimmune uveoretinitis induced by interphotoreceptor retinoid-binding protein.
    Kawashima H; Fujiño Y; Mochizuki M
    Jpn J Ophthalmol; 1991; 35(1):51-60. PubMed ID: 1895569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens.
    Caspi RR; Roberge FG; Chan CC; Wiggert B; Chader GJ; Rozenszajn LA; Lando Z; Nussenblatt RB
    J Immunol; 1988 Mar; 140(5):1490-5. PubMed ID: 3346541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orally induced bystander suppression in experimental autoimmune uveoretinitis occurs only in the periphery and not in the eye.
    Wildner G; Thurau SR
    Eur J Immunol; 1995 May; 25(5):1292-7. PubMed ID: 7774632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral tolerance in experimental autoimmune uveoretinitis. Distinct mechanisms of resistance are induced by low dose vs high dose feeding protocols.
    Gregerson DS; Obritsch WF; Donoso LA
    J Immunol; 1993 Nov; 151(10):5751-61. PubMed ID: 7693817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between the physiologic and morphologic changes in experimental autoimmune uveitis induced by peptide G of S-antigen.
    Hamasaki DI; Sato H; Santhanakrishnan S; Shinohara T
    Invest Ophthalmol Vis Sci; 1993 Apr; 34(5):1861-71. PubMed ID: 8473123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for selective accumulation of V beta 8+ T lymphocytes in experimental autoimmune uveoretinitis induced with two different retinal antigens.
    Egwuagu CE; Mahdi RM; Nussenblatt RB; Gery I; Caspi RR
    J Immunol; 1993 Aug; 151(3):1627-36. PubMed ID: 8393049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of experimental autoimmune uveoretinitis with intravitreal injection of tacrolimus (FK506) encapsulated in liposomes.
    Zhang R; He R; Qian J; Guo J; Xue K; Yuan YF
    Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3575-82. PubMed ID: 20164461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interphotoreceptor retinoid binding protein is a potent tolerogen in Lewis rat: suppression of experimental autoimmune uveoretinitis is retinal antigen specific.
    Laliotou B; Liversidge J; Forrester JV; Dick AD
    Br J Ophthalmol; 1997 Jan; 81(1):61-7. PubMed ID: 9135411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.